Quantcast
Last updated on April 18, 2014 at 16:31 EDT

Latest IMS Health Stories

2013-04-09 08:36:46

New company provides global investment technology to support the front, middle and back office BOSTON, April 9, 2013 /PRNewswire/ -- Eze Software Group today announced the completion of its launch as an independent provider of global, multi-asset class investment technology. Backed by TPG, the new company brings together the collective expertise and proven success of the RealTick® EMS, Eze OMS(TM) and Tradar PMS teams. Headquartered in Boston, MA, the new Eze Software Group is...

2013-04-03 16:24:16

PITTSBURGH, April 3, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Acyclovir Ointment USP, 5%. This product is the first generic version of Valeant International's Zovirax(® )Ointment, which is indicated in the management of initial genital herpes and in limited non-life-threatening mucocutaneous herpes...

2013-03-18 12:28:30

PITTSBURGH, March 18, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Specialty L.P. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levalbuterol Inhalation Solution USP, 0.31 mg/3 mL (0.0103%), 0.63 mg/3 mL (0.021%), and 1.25 mg/3 mL (0.042%), (Concentrate). This product is the generic version of Sunovion's Xopenex(® )Inhalation Solution, which is indicated for the...

2013-03-08 08:23:37

PARSIPPANY, N.J., March 8, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) today confirmed that it has filed with the U.S. Food and Drug Administration (FDA) an amendment to its Abbreviated New Drug Application (ANDA) for Rivastigmine Transdermal System to include the 13.3 mg per 24 hours dosage strength. Actavis' ANDA product is a generic version of Novartis' Exelon(®) Patch, which is a prescription medicine used to treat people with mild to moderate dementia associated with Alzheimer's...

2013-03-01 12:24:51

PARSIPPANY, N.J., March 1, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Testosterone gel 10mg/0.5g. Actavis' ANDA product is a generic version of Endo Pharmaceuticals' Fortesta(®), which is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone. Endo and...

2013-02-27 16:27:47

QUEBEC CITY, Feb. 27, 2013 /PRNewswire/ - Atrium Innovations Inc. (TSX: ATB), a globally recognized leader in the development, manufacturing and commercialization of innovative, science-based dietary supplements endorsed by health professionals, today announces that it has entered into a joint venture contract with Fosun Industrial, incorporated in Hong Kong, wholly owned of Shanghai-based Fosun Pharma for the purposes of distributing Atrium brands in China. According to IMS Health...

2013-02-25 08:30:29

PITTSBURGH, Feb. 25, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals has begun shipping Fenofibrate Capsules USP, 43 mg and 130 mg. This product is the generic version of Lupin Atlantis Holdings, S.A.'s Antara(®) Capsules, which are indicated as an adjunct to diet to reduce elevated LDL-C, Total-C, triglycerides, and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia and to reduce...

2013-02-25 08:28:16

PARSIPPANY, N.J., Feb. 25, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Buprenorphine HCl and Naloxone HCl Dihydrate SL Tablets, 2 mg/0.5 mg and 8 mg/2 mg, the generic equivalent to Reckitt Benckiser Healthcare's Suboxone(®). Actavis intends to begin shipping the product immediately. Suboxone(®) is indicated for maintenance treatment...

2013-02-19 08:33:59

MT. OLIVE, N.J., Feb. 19, 2013 /PRNewswire/ -- The Annual Pinsonault Managed Markets Summit begins Tuesday, February 26 at the InterContinental in Miami, FL. Among highlights, Captain Mark Kelly, Commander of the space shuttle Endeavour and retired U.S. Navy captain, will be one of the keynote presenters to take the stage during the three-day event. Kelly's wife, U.S. Congresswoman Gabby Giffords is also scheduled to make a guest appearance. Rounding out the keynote line-up, presenters...

2013-02-13 08:26:50

TEANECK, N.J., Feb. 13, 2013 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced that it has been positioned as a Leader in the IDC Health Insights "IDC MarketScape: Worldwide Life Science Drug Safety Services 2013 Vendor Assessment" (document number HI239221, dated February 2013). The IDC MarketScape report evaluated leading drug safety services (DSS) providers in the life science industry. The evaluation was based on a comprehensive framework, and assessed services providers across...